2020
DOI: 10.1016/j.cellsig.2020.109767
|View full text |Cite
|
Sign up to set email alerts
|

KLF5-mediated COX2 upregulation contributes to tumorigenesis driven by PTEN deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 38 publications
1
5
0
Order By: Relevance
“…Mycoplasma test was performed using TaKaRa PCR Mycoplasma Detection Set (Clontech Laboratories, EUA), before all experiments. For in vitro assays, the drug concentration was chosen as suggested by the manufacturer's protocols or according to previous studies [16][17][18][19][20] . Clinical samples of invasive breast cancer and their paired normal tissues (adjacent normal tissues) were obtained from patients undergoing surgical resection in the Department of Breast Surgery, the First Affiliated Hospital of Anhui Medical University from March 2017 to June 2019.…”
Section: Cell Cultures and Clinical Tissue Samplesmentioning
confidence: 99%
“…Mycoplasma test was performed using TaKaRa PCR Mycoplasma Detection Set (Clontech Laboratories, EUA), before all experiments. For in vitro assays, the drug concentration was chosen as suggested by the manufacturer's protocols or according to previous studies [16][17][18][19][20] . Clinical samples of invasive breast cancer and their paired normal tissues (adjacent normal tissues) were obtained from patients undergoing surgical resection in the Department of Breast Surgery, the First Affiliated Hospital of Anhui Medical University from March 2017 to June 2019.…”
Section: Cell Cultures and Clinical Tissue Samplesmentioning
confidence: 99%
“…Ma et al [29] showed that KLF5 reduced STAT3 activity and tumor metastasis in prostate cancer. Sun et al [30] reported that liver cancer cells with KLF5 knockdown displays a sharp and round shape and promotes mesenchymal-to-epithelial transition. Our experiments demonstrated that KLF5 is the target of miR-204 and functional assays revealed that KLF5 overexpression promoted PTC cell viability and invasion of PTC.…”
Section: Discussionmentioning
confidence: 99%
“…4 In addition to mPGES1, KLF5 was reported to induce cyclooxygenase 2 (COX2) expression and promote cell proliferation and migration in phosphate and tension homology deleted on chromosome ten (PTEN)-null mouse embryonic fibroblasts. 28 Consistently, KLF5 also promotes the transcription of Cyclin E1 by binding to its polymorphic enhancer in bladder cancer. 29 KLF5 was reported to promote bladder cancer cell migration by promoting the transcription of the FYN proto-oncogene kinase (FYN) gene, which thereby activates FAK.…”
Section: Tr An Scrip Ti Onal Targ E T G Ene Smentioning
confidence: 93%
“…Accumulating evidence from our laboratory has suggested that KLF5 promotes breast cancer by regulating several key target genes, including FGF‐BP1 , 25 microsomal prostaglandin E‐2 synthase 1 ( mPGES1 ), 26 tumor necrosis factor‐α ( TNFα ) ‐induced protein 2 ( TNFAIP2 ), 27 Slug , 7 and Cyclin D1 4 . In addition to mPGES1 , KLF5 was reported to induce cyclooxygenase 2 (COX2) expression and promote cell proliferation and migration in phosphate and tension homology deleted on chromosome ten (PTEN)‐null mouse embryonic fibroblasts 28 . Consistently, KLF5 also promotes the transcription of Cyclin E1 by binding to its polymorphic enhancer in bladder cancer 29 .…”
Section: Transcriptional Target Genesmentioning
confidence: 99%